Stay updated on OPUS Clinical Trial: Natalizumab in Focal Epilepsy

Sign up to get notified when there's something new on the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page.
Latest website image capture
Clouds background image

Latest updates to the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2 instead of v3.4.1; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T01:58:35.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision: v3.4.1 appears to replace the prior v3.4.0 without altering core study content or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T00:25:49.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The update adds a 'Show glossary' feature and a footer label 'Revision: v3.4.0', and includes small wording/capitalization tweaks such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T21:33:29.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.4, replacing v3.3.3, with no changes to study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:41:10.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added a comprehensive Locations section listing all study sites by state (Alabama, Arizona, California, District of Columbia, Florida, Hawaii, Illinois, Maryland, Massachusetts, Michigan, Missouri, New Jersey, New York, North Carolina, Ohio, Pennsylvania, South Carolina, Texas, Washington) and updated the revision tag from v3.3.2 to v3.3.3.
    Difference
    2%
    Check dated 2025-12-23T22:35:09.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    The PubMed publications section text was updated to state that entries are auto-filled from PubMed and may not pertain to the study, and the revision tag changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:22:30.000Z thumbnail image

Stay in the know with updates to OPUS Clinical Trial: Natalizumab in Focal Epilepsy

Enter your email address, and we'll notify you when there's something new on the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page.